首页 > 最新文献

Frontiers in Endocrinology最新文献

英文 中文
The landscape of recurrent spontaneous abortion registered on clinical trials.gov. 临床试验网站上登记的复发性自然流产的情况。
IF 3.9 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-12-20 eCollection Date: 2024-01-01 DOI: 10.3389/fendo.2024.1460968
Xiaoling Zhou, Fan Lai, Wei Chen, Congrong Zhou, Yi Deng, Tao Wang, Shasha Xing, Haoyang Diao, Mi Tang, Wenmei Guo, Erdan Luo

Objective: Recurrent spontaneous abortion (RSA) presents a significant challenge in the field of reproductive medicine, as effective treatments remain limited despite extensive research efforts. A comprehensive understanding of current RSA clinical trials is essential for enhancing trial design and identifying existing research gaps. The aim of this study is to characterize RSA related clinical trials registered on Clinical Trials.gov.

Methods: A thorough search was conducted to identify and review clinical trials focusing on RSA that were registered on Clinical Trials.gov up to March2, 2024.

Results: A total of 138 trials were identified in the analysis, with 72 (52.17%) classified as intervention trials and 66 (47.83%) as observational trials. Approximately half of the studies (67,48.55%) had an enrollment of 100 participants or fewer. The majority of trials included only female participants. Asia hosted the highest number of clinical trials (46,33.33%), followed by Europe (36,26.09%), Africa (29,21.01%), America (13,9.42%). The majority of trials (61,44.20%) focused on individuals with unexplained recurrent spontaneous abortion (URSA). The predominant intervention types examined in the reviewed studies were drug interventions (49,62.82%), with a notable rise in behavioral intervention trials.

Conclusion: Our research findings suggest that existing research efforts in the realm of RSA are inadequate for the progression of prevention and treatment strategies. The majority of clinical trials have primarily targeted individuals with URSA, with a particular emphasis on drug interventions, notably anticoagulants.

目的:复发性自然流产(RSA)是生殖医学领域的一个重大挑战,尽管进行了广泛的研究,但有效的治疗方法仍然有限。全面了解当前的RSA临床试验对于加强试验设计和确定现有的研究差距至关重要。本研究的目的是描述在clinical trials .gov上注册的RSA相关临床试验的特征。方法:进行了彻底的搜索,以识别和审查截至2024年3月2日在clinical trials .gov上注册的RSA相关临床试验。结果:本分析共纳入138项试验,其中干预试验72项(52.17%),观察试验66项(47.83%)。大约一半的研究(67,48.55%)的入组人数为100人或更少。大多数试验只包括女性参与者。亚洲的临床试验数量最多(46项,33.33%),其次是欧洲(36项,26.09%)、非洲(29项,21.01%)、美洲(13项,9.42%)。大多数试验(61,44.20%)集中于不明原因复发性自然流产(URSA)的个体。在回顾的研究中,主要的干预类型是药物干预(49,62.82%),行为干预试验显著增加。结论:我们的研究结果表明,目前在RSA领域的研究工作不足以促进预防和治疗策略的发展。大多数临床试验主要针对URSA患者,特别强调药物干预,特别是抗凝血剂。
{"title":"The landscape of recurrent spontaneous abortion registered on clinical trials.gov.","authors":"Xiaoling Zhou, Fan Lai, Wei Chen, Congrong Zhou, Yi Deng, Tao Wang, Shasha Xing, Haoyang Diao, Mi Tang, Wenmei Guo, Erdan Luo","doi":"10.3389/fendo.2024.1460968","DOIUrl":"https://doi.org/10.3389/fendo.2024.1460968","url":null,"abstract":"<p><strong>Objective: </strong>Recurrent spontaneous abortion (RSA) presents a significant challenge in the field of reproductive medicine, as effective treatments remain limited despite extensive research efforts. A comprehensive understanding of current RSA clinical trials is essential for enhancing trial design and identifying existing research gaps. The aim of this study is to characterize RSA related clinical trials registered on Clinical Trials.gov.</p><p><strong>Methods: </strong>A thorough search was conducted to identify and review clinical trials focusing on RSA that were registered on Clinical Trials.gov up to March2, 2024.</p><p><strong>Results: </strong>A total of 138 trials were identified in the analysis, with 72 (52.17%) classified as intervention trials and 66 (47.83%) as observational trials. Approximately half of the studies (67,48.55%) had an enrollment of 100 participants or fewer. The majority of trials included only female participants. Asia hosted the highest number of clinical trials (46,33.33%), followed by Europe (36,26.09%), Africa (29,21.01%), America (13,9.42%). The majority of trials (61,44.20%) focused on individuals with unexplained recurrent spontaneous abortion (URSA). The predominant intervention types examined in the reviewed studies were drug interventions (49,62.82%), with a notable rise in behavioral intervention trials.</p><p><strong>Conclusion: </strong>Our research findings suggest that existing research efforts in the realm of RSA are inadequate for the progression of prevention and treatment strategies. The majority of clinical trials have primarily targeted individuals with URSA, with a particular emphasis on drug interventions, notably anticoagulants.</p>","PeriodicalId":12447,"journal":{"name":"Frontiers in Endocrinology","volume":"15 ","pages":"1460968"},"PeriodicalIF":3.9,"publicationDate":"2024-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11695215/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142930111","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Studying targeted oxidation in diabetic cognitive dysfunction based on scientometrics analysis: research progress of natural product approaches. 基于科学计量学分析的糖尿病认知功能障碍的靶向氧化研究:天然产物方法的研究进展。
IF 3.9 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-12-20 eCollection Date: 2024-01-01 DOI: 10.3389/fendo.2024.1445750
Wenling Tu, Fuhang Xu, Jieying Li, Xiangfeng Tian, Lingyong Cao, Lei Wang, Yiqian Qu

Purpose: The aim is to provide new insights for researchers studying the pathogenesis of diabetic cognitive dysfunction and promoting the wider use of natural products in their treatment.

Method: First, the Web of Science Core Collection was selected as the data source for a computerized literature search on oxidative stress and diabetic cognitive dysfunction (DCD). Next, Biblimetrix and VOSviewer performed statistical analysis focusing on publication countries, institutions, authors, research hotspots, and emerging directions in the field. Then, through the analysis of keywords and key articles, the forefront of the field is identified. Finally, we discussed the pathogenesis of DCD, the influence of oxidative stress on DCD and the antioxidant effect of natural products on DCD.

Result: 293 valid papers were obtained. Bibliometrics showed that oxidative stress, diabetes, Alzheimer's disease (AD), cognitive decline, insulin resistance and quercetin were the key words of the symbiotic network.

Conclusion: The antioxidant effects of natural products in improving DCD have been extensively studied in preclinical studies, providing potential for their treatment in DCD, but their evaluation in clinical trials is currently uncommon.

目的:为研究糖尿病认知功能障碍的发病机制提供新的思路,促进天然产物在糖尿病认知功能障碍治疗中的广泛应用。方法:首先,选择Web of Science Core Collection作为数据源,对氧化应激与糖尿病认知功能障碍(DCD)进行计算机化文献检索。接下来,Biblimetrix和VOSviewer对该领域的出版国家、机构、作者、研究热点和新兴方向进行了统计分析。然后,通过对关键词和关键文章的分析,识别出该领域的前沿。最后讨论了DCD的发病机制、氧化应激对DCD的影响以及天然产物对DCD的抗氧化作用。结果:获得有效论文293篇。文献计量学显示,氧化应激、糖尿病、阿尔茨海默病(AD)、认知能力下降、胰岛素抵抗和槲皮素是该共生网络的关键词。结论:天然产物改善DCD的抗氧化作用在临床前研究中得到了广泛的研究,为其治疗DCD提供了潜力,但在临床试验中对其进行评价目前尚不常见。
{"title":"Studying targeted oxidation in diabetic cognitive dysfunction based on scientometrics analysis: research progress of natural product approaches.","authors":"Wenling Tu, Fuhang Xu, Jieying Li, Xiangfeng Tian, Lingyong Cao, Lei Wang, Yiqian Qu","doi":"10.3389/fendo.2024.1445750","DOIUrl":"10.3389/fendo.2024.1445750","url":null,"abstract":"<p><strong>Purpose: </strong>The aim is to provide new insights for researchers studying the pathogenesis of diabetic cognitive dysfunction and promoting the wider use of natural products in their treatment.</p><p><strong>Method: </strong>First, the Web of Science Core Collection was selected as the data source for a computerized literature search on oxidative stress and diabetic cognitive dysfunction (DCD). Next, Biblimetrix and VOSviewer performed statistical analysis focusing on publication countries, institutions, authors, research hotspots, and emerging directions in the field. Then, through the analysis of keywords and key articles, the forefront of the field is identified. Finally, we discussed the pathogenesis of DCD, the influence of oxidative stress on DCD and the antioxidant effect of natural products on DCD.</p><p><strong>Result: </strong>293 valid papers were obtained. Bibliometrics showed that oxidative stress, diabetes, Alzheimer's disease (AD), cognitive decline, insulin resistance and quercetin were the key words of the symbiotic network.</p><p><strong>Conclusion: </strong>The antioxidant effects of natural products in improving DCD have been extensively studied in preclinical studies, providing potential for their treatment in DCD, but their evaluation in clinical trials is currently uncommon.</p>","PeriodicalId":12447,"journal":{"name":"Frontiers in Endocrinology","volume":"15 ","pages":"1445750"},"PeriodicalIF":3.9,"publicationDate":"2024-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11695123/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142931089","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A comprehensive examination and analysis of the effectiveness and safety of finerenone for the treatment of diabetic kidney disease: a systematic review and meta-analysis. 芬尼酮治疗糖尿病肾病的有效性和安全性的综合检查和分析:系统回顾和荟萃分析。
IF 3.9 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-12-20 eCollection Date: 2024-01-01 DOI: 10.3389/fendo.2024.1461754
Jianyu Chen, Jisu Xue, Jiahui Chen, Tingfei Xie, Xiaolu Sui, Yanzi Zhang, Aisha Zhang, Yunpeng Xu, Jihong Chen

Objectives: The study will evaluate the effectiveness and safety of finerenone in patients diagnosed with diabetic kidney disease (DKD).

Methods: Various databases including PubMed, Sinomed, Web of Science, Embase, Clinical Trials, and Cochrane Library were systematically reviewed for pertinent studies published from the beginning to February 2024.This meta-analysis utilized RevMan 5.3 and Stata 15.1.

Results: The analysis of 4 randomized controlled trials involving 13,943 participants found that finerenone treatment significantly decreased the urine albumin-to-creatinine ratio compared to placebo. Additionally, the risk of COVID-19, cardiovascular events, and estimated glomerular filtration rate(eGFR) reduction of at least 40% were all significantly lower in the finerenone treatment group. However, the finerenone group did experience higher baseline increases in serum potassium levels. The meta-analysis revealed that there was no variation in the likelihood of general negative outcomes (RR 1.00, 95% CI 0.98, 1.01, I2 = 0%) and the occurrence of cancers (RR 0.99, 95% CI 0.83, 1.18,I2 = 0%) among the two categories.

Conclusion: Our study demonstrates that finerenone has the potential to lower the chances of end-stage kidney disease, renal failure and cardiovascular mortality in individuals with diabetic kidney disease. It is important to monitor for hyperkalemia risk. The administration of finelidone among individuals with diabetic kidney disease may potentially mitigate the susceptibility to contracting COVID-19.

Systematic review registration: https://www.crd.york.ac.uk/prospero/, identifier CRD42024536612.

目的:本研究将评估芬烯酮在糖尿病肾病(DKD)患者中的有效性和安全性。方法:系统检索PubMed、Sinomed、Web of Science、Embase、Clinical Trials、Cochrane Library等数据库自年初至2024年2月发表的相关研究。本meta分析采用RevMan 5.3和Stata 15.1。结果:对4项随机对照试验的分析,涉及13943名参与者发现,与安慰剂相比,芬纳酮治疗显著降低了尿白蛋白与肌酐比率。此外,细芬烯酮治疗组的COVID-19风险、心血管事件和估计肾小球滤过率(eGFR)降低至少40%均显著降低。然而,芬烯酮组的血清钾水平确实有较高的基线升高。荟萃分析显示,两类患者一般不良结局的可能性(RR 1.00, 95% CI 0.98, 1.01, I2 = 0%)和癌症发生的可能性(RR 0.99, 95% CI 0.83, 1.18,I2 = 0%)均无差异。结论:我们的研究表明,芬烯酮具有降低糖尿病肾病患者终末期肾病、肾功能衰竭和心血管疾病死亡率的潜力。监测高钾血症风险很重要。糖尿病肾病患者服用非利酮可能会降低感染COVID-19的易感性。系统综述注册:https://www.crd.york.ac.uk/prospero/,标识符CRD42024536612。
{"title":"A comprehensive examination and analysis of the effectiveness and safety of finerenone for the treatment of diabetic kidney disease: a systematic review and meta-analysis.","authors":"Jianyu Chen, Jisu Xue, Jiahui Chen, Tingfei Xie, Xiaolu Sui, Yanzi Zhang, Aisha Zhang, Yunpeng Xu, Jihong Chen","doi":"10.3389/fendo.2024.1461754","DOIUrl":"https://doi.org/10.3389/fendo.2024.1461754","url":null,"abstract":"<p><strong>Objectives: </strong>The study will evaluate the effectiveness and safety of finerenone in patients diagnosed with diabetic kidney disease (DKD).</p><p><strong>Methods: </strong>Various databases including PubMed, Sinomed, Web of Science, Embase, Clinical Trials, and Cochrane Library were systematically reviewed for pertinent studies published from the beginning to February 2024.This meta-analysis utilized RevMan 5.3 and Stata 15.1.</p><p><strong>Results: </strong>The analysis of 4 randomized controlled trials involving 13,943 participants found that finerenone treatment significantly decreased the urine albumin-to-creatinine ratio compared to placebo. Additionally, the risk of COVID-19, cardiovascular events, and estimated glomerular filtration rate(eGFR) reduction of at least 40% were all significantly lower in the finerenone treatment group. However, the finerenone group did experience higher baseline increases in serum potassium levels. The meta-analysis revealed that there was no variation in the likelihood of general negative outcomes (RR 1.00, 95% CI 0.98, 1.01, I<sup>2</sup> = 0%) and the occurrence of cancers (RR 0.99, 95% CI 0.83, 1.18,I<sup>2</sup> = 0%) among the two categories.</p><p><strong>Conclusion: </strong>Our study demonstrates that finerenone has the potential to lower the chances of end-stage kidney disease, renal failure and cardiovascular mortality in individuals with diabetic kidney disease. It is important to monitor for hyperkalemia risk. The administration of finelidone among individuals with diabetic kidney disease may potentially mitigate the susceptibility to contracting COVID-19.</p><p><strong>Systematic review registration: </strong>https://www.crd.york.ac.uk/prospero/, identifier CRD42024536612.</p>","PeriodicalId":12447,"journal":{"name":"Frontiers in Endocrinology","volume":"15 ","pages":"1461754"},"PeriodicalIF":3.9,"publicationDate":"2024-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11695223/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142931151","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between the Fatty Liver Index (FLI) and incident coronary heart disease: insights from a cohort study on the Chinese population. 脂肪肝指数(FLI)与冠心病发病率之间的关系:来自中国人群队列研究的见解
IF 3.9 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-12-20 eCollection Date: 2024-01-01 DOI: 10.3389/fendo.2024.1367853
Ying Miao, Yu Wang, Pijun Yan, Yi Li, Zhuang Chen, Nanwei Tong, Qin Wan

Background: The debate persists regarding whether metabolic dysfunction-associated steatotic liver disease (MASLD) actively contributes to coronary heart disease or merely acts as a passive indicator.

Objective: This research aims to clarify the relationship between liver fat accumulation, as quantified by FLI, and the risk of developing coronary heart disease.

Methods: Conducted from April to November 2011, the REACTION project, spearheaded by the Endocrinology Branch of the Chinese Medical Association, focused on Chinese adults aged 40 and above. Comprehensive data collection employed both questionnaires and specialized medical equipment, covering physical measurements, blood pressure, and pertinent biochemical markers. The study population excluded those with pre-existing coronary heart disease and acute myocardial infarction. Based on the initial data, participants were segmented and grouped into three categories. Analytically, the study utilized Cox proportional hazards models, further enhanced by stratified analyses to identify variations within predefined demographic groups.

Results: In this study, we enrolled 8,647 participants, comprising 2,887 males and 5,760 females. Over the 10-year non-interventional follow-up period, 433 participants (5%) passed away due to various reasons, with 55 deaths attributed to coronary heart disease/myocardial infarction, accounting for 12.7% of total deaths. Additionally, 484 participants were diagnosed with new-onset coronary heart disease, resulting in an incidence rate of 5.5%. Spearman correlation analysis revealed a positive correlation between FLI and traditional risk factors for coronary heart disease, including age, male gender, abnormal glucose metabolism, hypertension, smoking, TG, TC, LDL-C, etc. The Log-rank test indicated a rising cumulative incidence of coronary heart disease with increasing FLI groupings (P<0.01). Moreover, Cox regression analysis highlighted a notable correlation between FLI levels as a risk factor and the onset of coronary heart disease. After adjusting for other risk factors, individuals in the 30≤FLI<60 group exhibited a 1.203-fold higher risk of coronary heart disease compared to those in the FLI<30 group (p=0.126), while participants in the FLI≥60 group had a 1.386-fold higher risk than those in the FLI<30 group (p=0.041).

Conclusion: Elevated FLI values are strongly associated with an increased susceptibility to coronary heart disease, indicating its potential value as a prognostic marker for the condition.

背景:关于代谢功能障碍相关的脂肪变性肝病(MASLD)是否与冠心病有积极关系,或者仅仅是一个被动的指标,争论仍然存在。目的:本研究旨在阐明FLI量化的肝脏脂肪堆积与冠心病发生风险之间的关系。方法:由中华医学会内分泌学分会牵头,于2011年4月至11月对40岁及以上的中国成年人进行“反应”项目。综合数据收集采用问卷调查和专门的医疗设备,包括物理测量,血压和相关的生化指标。研究人群排除了已有冠心病和急性心肌梗死的人群。在初始数据的基础上,参与者被划分为三类。在分析上,研究使用Cox比例风险模型,并通过分层分析进一步增强,以确定预定义人口群体中的变化。结果:在本研究中,我们招募了8,647名参与者,其中男性2,887名,女性5,760名。在10年的非介入随访期间,433名参与者(5%)因各种原因死亡,其中55人死于冠心病/心肌梗死,占总死亡人数的12.7%。此外,484名参与者被诊断为新发冠心病,导致5.5%的发病率。Spearman相关分析显示,FLI与冠心病的传统危险因素(年龄、男性、糖代谢异常、高血压、吸烟、TG、TC、LDL-C等)呈正相关。Log-rank检验表明,随着FLI分组的增加,冠心病的累积发病率上升(结论:FLI值升高与冠心病易感性增加密切相关,表明其作为该病预后指标的潜在价值。
{"title":"Association between the Fatty Liver Index (FLI) and incident coronary heart disease: insights from a cohort study on the Chinese population.","authors":"Ying Miao, Yu Wang, Pijun Yan, Yi Li, Zhuang Chen, Nanwei Tong, Qin Wan","doi":"10.3389/fendo.2024.1367853","DOIUrl":"https://doi.org/10.3389/fendo.2024.1367853","url":null,"abstract":"<p><strong>Background: </strong>The debate persists regarding whether metabolic dysfunction-associated steatotic liver disease (MASLD) actively contributes to coronary heart disease or merely acts as a passive indicator.</p><p><strong>Objective: </strong>This research aims to clarify the relationship between liver fat accumulation, as quantified by FLI, and the risk of developing coronary heart disease.</p><p><strong>Methods: </strong>Conducted from April to November 2011, the REACTION project, spearheaded by the Endocrinology Branch of the Chinese Medical Association, focused on Chinese adults aged 40 and above. Comprehensive data collection employed both questionnaires and specialized medical equipment, covering physical measurements, blood pressure, and pertinent biochemical markers. The study population excluded those with pre-existing coronary heart disease and acute myocardial infarction. Based on the initial data, participants were segmented and grouped into three categories. Analytically, the study utilized Cox proportional hazards models, further enhanced by stratified analyses to identify variations within predefined demographic groups.</p><p><strong>Results: </strong>In this study, we enrolled 8,647 participants, comprising 2,887 males and 5,760 females. Over the 10-year non-interventional follow-up period, 433 participants (5%) passed away due to various reasons, with 55 deaths attributed to coronary heart disease/myocardial infarction, accounting for 12.7% of total deaths. Additionally, 484 participants were diagnosed with new-onset coronary heart disease, resulting in an incidence rate of 5.5%. Spearman correlation analysis revealed a positive correlation between FLI and traditional risk factors for coronary heart disease, including age, male gender, abnormal glucose metabolism, hypertension, smoking, TG, TC, LDL-C, etc. The Log-rank test indicated a rising cumulative incidence of coronary heart disease with increasing FLI groupings (P<0.01). Moreover, Cox regression analysis highlighted a notable correlation between FLI levels as a risk factor and the onset of coronary heart disease. After adjusting for other risk factors, individuals in the 30≤FLI<60 group exhibited a 1.203-fold higher risk of coronary heart disease compared to those in the FLI<30 group (p=0.126), while participants in the FLI≥60 group had a 1.386-fold higher risk than those in the FLI<30 group (p=0.041).</p><p><strong>Conclusion: </strong>Elevated FLI values are strongly associated with an increased susceptibility to coronary heart disease, indicating its potential value as a prognostic marker for the condition.</p>","PeriodicalId":12447,"journal":{"name":"Frontiers in Endocrinology","volume":"15 ","pages":"1367853"},"PeriodicalIF":3.9,"publicationDate":"2024-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11695934/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142931153","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Umbilical vein remodeling is associated with pregestational maternal overweight. 脐静脉重构与妊娠期孕妇超重有关。
IF 3.9 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-12-20 eCollection Date: 2024-01-01 DOI: 10.3389/fendo.2024.1483364
Kamilla Batista da Silva Souza, Luana Caroline Hochberger, Felippe Egon Castrignano Camargo, Gabriely Santos Silva, Giovanna Castrignano Camargo, João Pedro Lourenço Mello, Fernanda Cristina Alcantara Dos Santos, Fernanda Regina Giachini, Núbia de Souza Lobato, Paula Cristina de Souza Souto

Introduction: Excess weight during pregnancy is a condition that can affect both mother and fetus, through the maternal-fetal interface, which is constituted by the placenta and umbilical cord. The umbilical vein is responsible for transporting oxygen and nutrients to the fetus, and its proper functioning depends on the integrity of its structure. The remodeling of the umbilical vein represents one of the causes of inadequate transport of nutrients to the fetus, being potentially harmful. This study aims to evaluate whether maternal overweight alters the structural characteristics of the umbilical vein.

Methods: Umbilical cords were collected from eutrophic and overweight pregnant women and were processed according to histological routine. We analyzed morphometry parameters, collagen and elastin fibers deposition, glycosaminoglycan level, and cell proliferation.

Results: Veins from overweight pregnant women were found to have greater total area, wall area, wall thickness, and diameter. There was higher collagen labeling in the perivascular region of the overweight group and a higher amount of type III collagen in the vascular smooth muscle. The proliferation of muscle and perivascular cells was higher in overweight pregnant women. A positive, although weak, correlation was observed between BMI and vessel thickness and with type III collagen deposition in vascular smooth muscle.

Discussion: With this study, we show that being overweight can structurally alter the umbilical vein, causing vascular remodeling of the vessel, through hypertrophy and hyperplasia.

孕期超重是一种通过胎盘和脐带构成的母胎界面影响母体和胎儿的情况。脐静脉负责向胎儿输送氧气和营养物质,其正常功能取决于其结构的完整性。脐静脉的重塑是导致营养物质输送到胎儿不足的原因之一,具有潜在的危害。本研究旨在评估孕妇超重是否会改变脐静脉的结构特征。方法:采集富营养化和超重孕妇脐带,按组织学常规处理。我们分析了形态学参数、胶原和弹性蛋白纤维沉积、糖胺聚糖水平和细胞增殖。结果:超重孕妇静脉的总面积、壁面积、壁厚和直径均较大。超重组血管周围区胶原标记量较高,血管平滑肌中III型胶原含量较高。超重孕妇的肌肉和血管周围细胞的增殖较高。BMI与血管厚度和血管平滑肌中III型胶原沉积呈正相关,但相关性较弱。讨论:通过这项研究,我们发现超重可以从结构上改变脐静脉,通过肥大和增生引起血管重塑。
{"title":"Umbilical vein remodeling is associated with pregestational maternal overweight.","authors":"Kamilla Batista da Silva Souza, Luana Caroline Hochberger, Felippe Egon Castrignano Camargo, Gabriely Santos Silva, Giovanna Castrignano Camargo, João Pedro Lourenço Mello, Fernanda Cristina Alcantara Dos Santos, Fernanda Regina Giachini, Núbia de Souza Lobato, Paula Cristina de Souza Souto","doi":"10.3389/fendo.2024.1483364","DOIUrl":"https://doi.org/10.3389/fendo.2024.1483364","url":null,"abstract":"<p><strong>Introduction: </strong>Excess weight during pregnancy is a condition that can affect both mother and fetus, through the maternal-fetal interface, which is constituted by the placenta and umbilical cord. The umbilical vein is responsible for transporting oxygen and nutrients to the fetus, and its proper functioning depends on the integrity of its structure. The remodeling of the umbilical vein represents one of the causes of inadequate transport of nutrients to the fetus, being potentially harmful. This study aims to evaluate whether maternal overweight alters the structural characteristics of the umbilical vein.</p><p><strong>Methods: </strong>Umbilical cords were collected from eutrophic and overweight pregnant women and were processed according to histological routine. We analyzed morphometry parameters, collagen and elastin fibers deposition, glycosaminoglycan level, and cell proliferation.</p><p><strong>Results: </strong>Veins from overweight pregnant women were found to have greater total area, wall area, wall thickness, and diameter. There was higher collagen labeling in the perivascular region of the overweight group and a higher amount of type III collagen in the vascular smooth muscle. The proliferation of muscle and perivascular cells was higher in overweight pregnant women. A positive, although weak, correlation was observed between BMI and vessel thickness and with type III collagen deposition in vascular smooth muscle.</p><p><strong>Discussion: </strong>With this study, we show that being overweight can structurally alter the umbilical vein, causing vascular remodeling of the vessel, through hypertrophy and hyperplasia.</p>","PeriodicalId":12447,"journal":{"name":"Frontiers in Endocrinology","volume":"15 ","pages":"1483364"},"PeriodicalIF":3.9,"publicationDate":"2024-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11695124/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142930945","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ramulus Mori (Sangzhi) alkaloids ameliorate high-fat diet induced obesity in rats by modulating gut microbiota and bile acid metabolism. 桑枝生物碱通过调节肠道菌群和胆汁酸代谢改善高脂饮食诱导的大鼠肥胖。
IF 3.9 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-12-20 eCollection Date: 2024-01-01 DOI: 10.3389/fendo.2024.1506430
Xin Shang, Yu Fu, Ying Wang, Shuxun Yan
<p><strong>Objective: </strong>The objective of this study is to investigate the ability of Ramulus Mori (Sangzhi) alkaloid tablets (SZ-A) to ameliorate obesity and lipid metabolism disorders in rats subjected to a high-fat diet (HFD) through metagenomics, untargeted lipidomics, targeted metabolism of bile acid (BA), and BA pathways, providing a novel perspective on the management of metabolic disorders.</p><p><strong>Methods: </strong>In this research, HFD-fed rats were concurrently administered SZ-A orally. We measured changes in body weight (BW), blood lipid profiles, and liver function to assess therapeutic effects. Liver lipid status was visualized through H&E and Oil Red O. Gut microbiota composition was elucidated using metagenomics. The LC-MS-targeted metabolomics approach was utilized to define the fecal BA profiles. Furthermore, the lipid metabolomics of adipose tissue samples was investigated using an LC-MS analysis platform. The expression levels of the BA receptor were determined by western blotting. Additionally, serum insulin (INS), glucagon-like peptide-1 (GLP-1), and inflammatory cytokines were quantified using an ELISA kit. The integrity of the colonic epithelial barrier was assessed using immunofluorescence.</p><p><strong>Results: </strong>SZ-A notably decreased BW and blood lipid levels in obese rats while also alleviating liver injury. Additionally, SZ-A reduced the serum levels of leptin (LEP), INS, and GLP-1, indicating its potential to modulate key metabolic hormones. Most notably, SZ-A substantially improved gut microbiota composition. Specifically, it reshaped the gut microbiota structure in HFD-fed rats by increasing the relative abundance of beneficial bacteria, such as <i>Bacteroides</i>, while decreasing the populations of potentially harmful bacteria, such as <i>Dorea</i> and <i>Blautia</i>. At the BA level, SZ-A decreased the levels of harmful BAs, including hyodeoxycholic acid (HDCA), deoxycholic acid (DCA), 12-keto lithocholic acid (12-KLCA), lithocholic acid (LCA), and muricholic acid (MDCA). Between the model group and SZ-A, 258 differentially abundant metabolites were detected, with 72 upregulated and 186 downregulated. Furthermore, these BAs are implicated in the activation of the FXR-FGF15 and TGR5-GLP-1 pathways in the intestine. This activation helps to alleviate HFD-fed intestinal inflammation and restore intestinal barrier damage by modulating inflammatory cytokines and bolstering the intestinal barrier's capabilities.</p><p><strong>Conclusions: </strong>Our findings indicate that SZ-A effectively modulates BW, serum lipid profiles, and liver function in HFD-fed rats. Moreover, SZ-A exerts a positive influence on inflammatory cytokines, thereby mitigating inflammation and promoting the restoration of the intestinal barrier. Significantly, our research indicates that adjusting the gut microbiome and BA levels could serve as an effective approach for both preventing and treating obesity and related metabol
目的:研究桑枝生物碱片(SZ-A)通过宏基因组学、非靶向脂质组学、靶向胆汁酸代谢(BA)及BA通路等方法改善高脂饮食(HFD)大鼠肥胖和脂质代谢紊乱的能力,为代谢紊乱的治疗提供新的视角。方法:在本研究中,hfd喂养的大鼠同时口服SZ-A。我们测量了体重(BW)、血脂和肝功能的变化来评估治疗效果。通过H&E和Oil Red o可视化肝脏脂质状态。通过宏基因组学阐明肠道微生物群组成。利用lc - ms靶向代谢组学方法确定粪便BA谱。此外,使用LC-MS分析平台对脂肪组织样本的脂质代谢组学进行了研究。western blotting检测BA受体表达水平。此外,用ELISA试剂盒定量测定血清胰岛素(INS)、胰高血糖素样肽-1 (GLP-1)和炎症因子。使用免疫荧光法评估结肠上皮屏障的完整性。结果:SZ-A显著降低肥胖大鼠体重和血脂水平,减轻肝损伤。此外,SZ-A降低了血清瘦素(LEP)、INS和GLP-1的水平,表明其调节关键代谢激素的潜力。最值得注意的是,SZ-A显著改善了肠道菌群组成。具体来说,它通过增加有益细菌(如拟杆菌)的相对丰度,同时减少潜在有害细菌(如Dorea和Blautia)的数量,重塑了喂食hfd的大鼠的肠道微生物群结构。在BA水平上,SZ-A降低了有害BAs的水平,包括羟基去氧胆酸(HDCA)、脱氧胆酸(DCA)、12-酮石胆酸(12-KLCA)、石胆酸(LCA)和胆酸(MDCA)。在模型组和SZ-A之间,检测到258种差异丰富的代谢物,其中72种表达上调,186种表达下调。此外,这些BAs与肠道中FXR-FGF15和TGR5-GLP-1通路的激活有关。这种激活有助于减轻hfd引起的肠道炎症,并通过调节炎症细胞因子和增强肠道屏障的能力来恢复肠道屏障的损伤。结论:我们的研究结果表明,SZ-A可以有效地调节hfd喂养大鼠的体重、血脂和肝功能。此外,SZ-A对炎症因子有积极影响,从而减轻炎症,促进肠道屏障的修复。值得注意的是,我们的研究表明,调节肠道微生物群和BA水平可以作为预防和治疗肥胖及相关代谢血脂异常的有效途径。
{"title":"Ramulus Mori (Sangzhi) alkaloids ameliorate high-fat diet induced obesity in rats by modulating gut microbiota and bile acid metabolism.","authors":"Xin Shang, Yu Fu, Ying Wang, Shuxun Yan","doi":"10.3389/fendo.2024.1506430","DOIUrl":"https://doi.org/10.3389/fendo.2024.1506430","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;The objective of this study is to investigate the ability of Ramulus Mori (Sangzhi) alkaloid tablets (SZ-A) to ameliorate obesity and lipid metabolism disorders in rats subjected to a high-fat diet (HFD) through metagenomics, untargeted lipidomics, targeted metabolism of bile acid (BA), and BA pathways, providing a novel perspective on the management of metabolic disorders.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;In this research, HFD-fed rats were concurrently administered SZ-A orally. We measured changes in body weight (BW), blood lipid profiles, and liver function to assess therapeutic effects. Liver lipid status was visualized through H&E and Oil Red O. Gut microbiota composition was elucidated using metagenomics. The LC-MS-targeted metabolomics approach was utilized to define the fecal BA profiles. Furthermore, the lipid metabolomics of adipose tissue samples was investigated using an LC-MS analysis platform. The expression levels of the BA receptor were determined by western blotting. Additionally, serum insulin (INS), glucagon-like peptide-1 (GLP-1), and inflammatory cytokines were quantified using an ELISA kit. The integrity of the colonic epithelial barrier was assessed using immunofluorescence.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;SZ-A notably decreased BW and blood lipid levels in obese rats while also alleviating liver injury. Additionally, SZ-A reduced the serum levels of leptin (LEP), INS, and GLP-1, indicating its potential to modulate key metabolic hormones. Most notably, SZ-A substantially improved gut microbiota composition. Specifically, it reshaped the gut microbiota structure in HFD-fed rats by increasing the relative abundance of beneficial bacteria, such as &lt;i&gt;Bacteroides&lt;/i&gt;, while decreasing the populations of potentially harmful bacteria, such as &lt;i&gt;Dorea&lt;/i&gt; and &lt;i&gt;Blautia&lt;/i&gt;. At the BA level, SZ-A decreased the levels of harmful BAs, including hyodeoxycholic acid (HDCA), deoxycholic acid (DCA), 12-keto lithocholic acid (12-KLCA), lithocholic acid (LCA), and muricholic acid (MDCA). Between the model group and SZ-A, 258 differentially abundant metabolites were detected, with 72 upregulated and 186 downregulated. Furthermore, these BAs are implicated in the activation of the FXR-FGF15 and TGR5-GLP-1 pathways in the intestine. This activation helps to alleviate HFD-fed intestinal inflammation and restore intestinal barrier damage by modulating inflammatory cytokines and bolstering the intestinal barrier's capabilities.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;Our findings indicate that SZ-A effectively modulates BW, serum lipid profiles, and liver function in HFD-fed rats. Moreover, SZ-A exerts a positive influence on inflammatory cytokines, thereby mitigating inflammation and promoting the restoration of the intestinal barrier. Significantly, our research indicates that adjusting the gut microbiome and BA levels could serve as an effective approach for both preventing and treating obesity and related metabol","PeriodicalId":12447,"journal":{"name":"Frontiers in Endocrinology","volume":"15 ","pages":"1506430"},"PeriodicalIF":3.9,"publicationDate":"2024-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11695234/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142931087","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A stress paradox: the dual role of the unfolded protein response in the placenta. 应激悖论:未折叠蛋白反应在胎盘中的双重作用。
IF 3.9 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-12-20 eCollection Date: 2024-01-01 DOI: 10.3389/fendo.2024.1525189
Diba Chowdhury, Chloe E Jang, Patrick Lajoie, Stephen J Renaud

The placenta is a temporary organ that forms during pregnancy and is essential for fetal development and maternal health. As an endocrine organ, proper placental function requires continual production, folding, and transport of proteins and lipids. Central to these processes is the endoplasmic reticulum (ER), a dynamic organelle responsible for maintaining cellular protein and lipid synthesis and processing. ER stress occurs when there is an accumulation of unfolded or misfolded proteins, which triggers the activation of cellular pathways collectively called the unfolded protein response. Unfolded protein response pathways act to alleviate the misfolded protein burden and restore ER homeostasis, or if unresolved, initiate cell death. While prolonged ER stress has been linked to deficient placental function and adverse pregnancy outcomes, basal activation of unfolded protein response pathways is required for placental development and function. This review explores the importance of ER homeostasis in placental development and function, examining how disruptions in ER stress responses may contribute to adverse pregnancy outcomes.

胎盘是怀孕期间形成的临时器官,对胎儿发育和母亲健康至关重要。作为一个内分泌器官,正常的胎盘功能需要持续的蛋白质和脂质的产生、折叠和运输。这些过程的中心是内质网(ER),一个负责维持细胞蛋白质和脂质合成和加工的动态细胞器。当未折叠或错误折叠的蛋白质积累时,内质网应激就会发生,这会触发细胞通路的激活,统称为未折叠蛋白质反应。未折叠的蛋白质反应途径可以减轻错误折叠的蛋白质负担并恢复内质网稳态,或者如果未解决,则启动细胞死亡。虽然长期内质网应激与胎盘功能缺陷和不良妊娠结局有关,但未折叠蛋白反应途径的基础激活是胎盘发育和功能所必需的。这篇综述探讨了内质网稳态在胎盘发育和功能中的重要性,研究了内质网应激反应的破坏如何导致不良妊娠结局。
{"title":"A stress paradox: the dual role of the unfolded protein response in the placenta.","authors":"Diba Chowdhury, Chloe E Jang, Patrick Lajoie, Stephen J Renaud","doi":"10.3389/fendo.2024.1525189","DOIUrl":"https://doi.org/10.3389/fendo.2024.1525189","url":null,"abstract":"<p><p>The placenta is a temporary organ that forms during pregnancy and is essential for fetal development and maternal health. As an endocrine organ, proper placental function requires continual production, folding, and transport of proteins and lipids. Central to these processes is the endoplasmic reticulum (ER), a dynamic organelle responsible for maintaining cellular protein and lipid synthesis and processing. ER stress occurs when there is an accumulation of unfolded or misfolded proteins, which triggers the activation of cellular pathways collectively called the unfolded protein response. Unfolded protein response pathways act to alleviate the misfolded protein burden and restore ER homeostasis, or if unresolved, initiate cell death. While prolonged ER stress has been linked to deficient placental function and adverse pregnancy outcomes, basal activation of unfolded protein response pathways is required for placental development and function. This review explores the importance of ER homeostasis in placental development and function, examining how disruptions in ER stress responses may contribute to adverse pregnancy outcomes.</p>","PeriodicalId":12447,"journal":{"name":"Frontiers in Endocrinology","volume":"15 ","pages":"1525189"},"PeriodicalIF":3.9,"publicationDate":"2024-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11695235/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142931152","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The impact of telemedicine on pediatric type 1 diabetes management: benefits, challenges, and future directions. 远程医疗对儿童1型糖尿病管理的影响:益处、挑战和未来方向
IF 3.9 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-12-20 eCollection Date: 2024-01-01 DOI: 10.3389/fendo.2024.1513166
Susanna Esposito, Vanessa Sambati, Federica Fogliazza, Maria Elisabeth Street, Nicola Principi

Telemedicine (TM) has emerged as a valuable tool in managing pediatric type 1 diabetes (T1D), particularly during the COVID-19 pandemic when traditional in-person visits were limited. This narrative review examines the impact of TM on patient-provider relationships, glycemic control, and overall diabetes management in children and adolescents with T1D. Studies consistently demonstrate high levels of patient and provider satisfaction with TM, citing increased consultation frequency, reduced travel burdens, and lower associated costs. However, results regarding the effect of TM on glycemic control, as measured by HbA1c levels, are inconsistent. Some studies show significant reductions in HbA1c levels with TM use, while others report outcomes comparable to or less effective than traditional care. The effectiveness of TM also appears to be influenced by the concurrent use of advanced diabetes technologies, such as continuous glucose monitors and automated insulin delivery systems. Furthermore, TM's impact on quality of life and other clinical outcomes beyond glucose management remains underexplored. Methodological limitations, including inconsistent randomization strategies and lack of long-term follow-up, hinder definitive conclusions. Despite these uncertainties, TM offers several advantages, such as improved accessibility and patient engagement, which may justify its broader implementation. Future research should focus on optimizing TM approaches to enhance glycemic control and quality of life, identifying the most effective strategies for specific patient groups, and addressing technological and economic barriers. This review highlights the need for comprehensive, long-term studies to fully understand TM's potential in pediatric T1D management and its integration into standard care practices.

远程医疗已成为治疗儿童1型糖尿病(T1D)的宝贵工具,特别是在COVID-19大流行期间,传统的亲自就诊受到限制。这篇叙述性综述探讨了TM对儿童和青少年T1D患者的医患关系、血糖控制和整体糖尿病管理的影响。研究一致表明,患者和提供者对TM的满意度很高,理由是增加了咨询频率,减轻了旅行负担,降低了相关成本。然而,关于TM对血糖控制的影响,通过HbA1c水平测量的结果是不一致的。一些研究显示,使用TM可显著降低HbA1c水平,而另一些研究报告的结果与传统治疗相当或不如传统治疗有效。TM的有效性似乎也受到先进糖尿病技术(如连续血糖监测仪和自动胰岛素输送系统)同时使用的影响。此外,除血糖管理外,TM对生活质量和其他临床结果的影响仍未得到充分探讨。方法学的局限性,包括不一致的随机化策略和缺乏长期随访,阻碍了明确的结论。尽管存在这些不确定因素,传统医学仍有一些优势,如改善了可及性和患者参与度,这可能证明其广泛实施是合理的。未来的研究应侧重于优化TM方法以提高血糖控制和生活质量,为特定患者群体确定最有效的策略,并解决技术和经济障碍。本综述强调需要进行全面、长期的研究,以充分了解TM在儿童T1D管理中的潜力,并将其纳入标准护理实践。
{"title":"The impact of telemedicine on pediatric type 1 diabetes management: benefits, challenges, and future directions.","authors":"Susanna Esposito, Vanessa Sambati, Federica Fogliazza, Maria Elisabeth Street, Nicola Principi","doi":"10.3389/fendo.2024.1513166","DOIUrl":"https://doi.org/10.3389/fendo.2024.1513166","url":null,"abstract":"<p><p>Telemedicine (TM) has emerged as a valuable tool in managing pediatric type 1 diabetes (T1D), particularly during the COVID-19 pandemic when traditional in-person visits were limited. This narrative review examines the impact of TM on patient-provider relationships, glycemic control, and overall diabetes management in children and adolescents with T1D. Studies consistently demonstrate high levels of patient and provider satisfaction with TM, citing increased consultation frequency, reduced travel burdens, and lower associated costs. However, results regarding the effect of TM on glycemic control, as measured by HbA1c levels, are inconsistent. Some studies show significant reductions in HbA1c levels with TM use, while others report outcomes comparable to or less effective than traditional care. The effectiveness of TM also appears to be influenced by the concurrent use of advanced diabetes technologies, such as continuous glucose monitors and automated insulin delivery systems. Furthermore, TM's impact on quality of life and other clinical outcomes beyond glucose management remains underexplored. Methodological limitations, including inconsistent randomization strategies and lack of long-term follow-up, hinder definitive conclusions. Despite these uncertainties, TM offers several advantages, such as improved accessibility and patient engagement, which may justify its broader implementation. Future research should focus on optimizing TM approaches to enhance glycemic control and quality of life, identifying the most effective strategies for specific patient groups, and addressing technological and economic barriers. This review highlights the need for comprehensive, long-term studies to fully understand TM's potential in pediatric T1D management and its integration into standard care practices.</p>","PeriodicalId":12447,"journal":{"name":"Frontiers in Endocrinology","volume":"15 ","pages":"1513166"},"PeriodicalIF":3.9,"publicationDate":"2024-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11695225/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142931178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Novel MKRN3 gene mutation associated with central precocious puberty in a Chinese child: a case report. 与中国儿童中枢性性早熟相关的新型MKRN3基因突变1例报告
IF 3.9 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-12-20 eCollection Date: 2024-01-01 DOI: 10.3389/fendo.2024.1491664
Jingna Wang, Rongmin Li, Jieying Wang, Di Wu, Shuqin Lei, Yanmei Sang, Jie Chang

Objective: The objective of this study is to investigate the clinical presentation and underlying genetic etiology of a Chinese child diagnosed with idiopathic central precocious puberty (ICPP).

Methods: Clinical data from a pediatric patient with ICPP, including medical history, physical examination findings, laboratory results, and imaging studies, were collected and analyzed. Whole exome sequencing (WES) was performed to identify potential pathogenic genetic variants underlying the patient's ICPP.

Results: A 4 ¾-year-old female patient presented with precocious puberty, characterized by accelerated growth, Tanner stage II breast development, and Tanner stage I pubic hair. A café-au-lait macule was observed on the patient's right flank. WES revealed a novel makorin RING finger protein 3 (MKRN3) gene heterozygous frameshift pathogenic variant c.1219delA (p.R407Gfs*75), which was inherited from the patient's asymptomatic father, and leading to a truncated protein 73 amino acids downstream from the mutation site.

Conclusion: This case underscores the genetic heterogeneity of ICPP and further implicates MKRN3 gene mutations in its pathogenesis. The identification of this novel pathogenic variant expands the known mutational spectrum associated with ICPP, particularly within the Chinese pediatric population. Comprehensive genetic testing should be considered in pediatric patients presenting with early-onset ICPP to facilitate accurate diagnosis, inform genetic counseling, and guide personalized management strategies.

目的:探讨1例中国儿童特发性中枢性性早熟(idiopathic central preco性puberty, ICPP)的临床表现和潜在的遗传病因。方法:收集并分析1例小儿ICPP患者的临床资料,包括病史、体格检查、实验室结果和影像学检查。进行全外显子组测序(WES)以确定患者ICPP潜在的致病遗传变异。结果:一名4又3 / 4岁的女性患者表现为性早熟,以生长加速、Tanner II期乳房发育和Tanner I期阴毛为特征。患者右侧可见一卡萨梅-奥莱斑疹。WES发现了一种新的makorin RING finger protein 3 (MKRN3)基因杂合移码致病性变异体c.1219delA (p.R407Gfs*75),该变异体遗传自患者无症状父亲,在突变位点下游有一个73个氨基酸的蛋白被截断。结论:本病例强调了ICPP的遗传异质性,并进一步提示MKRN3基因突变参与其发病机制。这种新的致病变异的鉴定扩大了与ICPP相关的已知突变谱,特别是在中国儿科人群中。对于出现早发性ICPP的儿童患者,应考虑进行全面的基因检测,以促进准确诊断,提供遗传咨询,并指导个性化的治疗策略。
{"title":"Novel <i>MKRN3</i> gene mutation associated with central precocious puberty in a Chinese child: a case report.","authors":"Jingna Wang, Rongmin Li, Jieying Wang, Di Wu, Shuqin Lei, Yanmei Sang, Jie Chang","doi":"10.3389/fendo.2024.1491664","DOIUrl":"https://doi.org/10.3389/fendo.2024.1491664","url":null,"abstract":"<p><strong>Objective: </strong>The objective of this study is to investigate the clinical presentation and underlying genetic etiology of a Chinese child diagnosed with idiopathic central precocious puberty (ICPP).</p><p><strong>Methods: </strong>Clinical data from a pediatric patient with ICPP, including medical history, physical examination findings, laboratory results, and imaging studies, were collected and analyzed. Whole exome sequencing (WES) was performed to identify potential pathogenic genetic variants underlying the patient's ICPP.</p><p><strong>Results: </strong>A 4 ¾-year-old female patient presented with precocious puberty, characterized by accelerated growth, Tanner stage II breast development, and Tanner stage I pubic hair. A café-au-lait macule was observed on the patient's right flank. WES revealed a novel makorin RING finger protein 3 (<i>MKRN3</i>) gene heterozygous frameshift pathogenic variant c.1219delA (p.R407Gfs*75), which was inherited from the patient's asymptomatic father, and leading to a truncated protein 73 amino acids downstream from the mutation site.</p><p><strong>Conclusion: </strong>This case underscores the genetic heterogeneity of ICPP and further implicates <i>MKRN3</i> gene mutations in its pathogenesis. The identification of this novel pathogenic variant expands the known mutational spectrum associated with ICPP, particularly within the Chinese pediatric population. Comprehensive genetic testing should be considered in pediatric patients presenting with early-onset ICPP to facilitate accurate diagnosis, inform genetic counseling, and guide personalized management strategies.</p>","PeriodicalId":12447,"journal":{"name":"Frontiers in Endocrinology","volume":"15 ","pages":"1491664"},"PeriodicalIF":3.9,"publicationDate":"2024-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11695779/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142931155","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Balancing choice and socioeconomic realities: analyzing behavioral and economic factors in social oocyte cryopreservation decisions. 平衡选择和社会经济现实:分析社会卵母细胞冷冻保存决策中的行为和经济因素。
IF 3.9 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-12-20 eCollection Date: 2024-01-01 DOI: 10.3389/fendo.2024.1467213
Limor Dina Gonen

Purpose: This research investigates the influence of personal income, the likelihood of pregnancy from cryopreserved oocytes, and the risk of infertility, on the decision-making process of women. The study employs the economic stated preference framework alongside the Theory of Planned Behavior in order to comprehend the process of decision-making.

Design/methodology/approach: The data had been collected from women between the ages of 18 and 65 via questionnaire employing conjoint analysis (CA). Through the utilization of this methodology, the factors influencing women's choices concerning oocyte cryopreservation were quantified.

Findings: The study identified crucial factors that impact the determination to cryopreserve oocytes, such as personal financial resources, the likelihood of achieving a successful pregnancy using frozen oocytes, and the potential for infertility. The analysis reveals that a considerable number of participants perceive cryopreservation as a feasible alternative for augmenting their prospects for future procreation.

Research implications: The results validate the patterns and the ways in which personal and socioeconomic elements impact choices regarding fertility. This has the potential to inform forthcoming health policies and educational initiatives that aim to provide more comprehensive support for women's fertility decisions.

Social implications: The research highlights the necessity of policy and societal support for women who are contemplating oocyte cryopreservation. It is recommended that public health policies incorporate provisions for state financing of cryopreservation in order to safeguard reproductive autonomy and alleviate the fertility risk linked to the aging process.

Originality/value: His research is unique in that it employs the Theory of Planned Behavior and an economic stated-preference framework to analyze the dynamics of oocyte cryopreservation decisions. This work enhances the existing body of literature by drawing attention to the socio-economic persona factors that influence choices regarding fertility preservation.

目的:本研究探讨个人收入、冷冻卵母细胞妊娠可能性和不孕风险对女性生育决策的影响。为了理解决策过程,本研究采用了经济陈述偏好框架和计划行为理论。设计/方法/方法:通过联合分析(CA)问卷调查,从18至65岁的女性中收集数据。运用该方法,对影响妇女卵母细胞冷冻保存选择的因素进行了定量分析。研究发现:该研究确定了影响冷冻保存卵母细胞决定的关键因素,如个人经济资源、使用冷冻卵母细胞成功怀孕的可能性以及不孕的可能性。分析表明,相当多的参与者认为低温保存是增加他们未来生育前景的可行选择。研究启示:研究结果验证了个人和社会经济因素影响生育选择的模式和方式。这有可能为即将出台的旨在为妇女生育决定提供更全面支持的保健政策和教育举措提供信息。社会影响:该研究强调了对考虑卵母细胞冷冻保存的妇女提供政策和社会支持的必要性。建议公共卫生政策纳入国家资助冷冻保存的规定,以保障生殖自主权,减轻与老龄化过程有关的生育风险。原创性/价值:他的研究是独一无二的,因为它采用了计划行为理论和经济的陈述偏好框架来分析卵母细胞冷冻保存决策的动态。这项工作通过提请注意影响生育保护选择的社会经济人物因素,增强了现有的文献。
{"title":"Balancing choice and socioeconomic realities: analyzing behavioral and economic factors in social oocyte cryopreservation decisions.","authors":"Limor Dina Gonen","doi":"10.3389/fendo.2024.1467213","DOIUrl":"https://doi.org/10.3389/fendo.2024.1467213","url":null,"abstract":"<p><strong>Purpose: </strong>This research investigates the influence of personal income, the likelihood of pregnancy from cryopreserved oocytes, and the risk of infertility, on the decision-making process of women. The study employs the economic stated preference framework alongside the Theory of Planned Behavior in order to comprehend the process of decision-making.</p><p><strong>Design/methodology/approach: </strong>The data had been collected from women between the ages of 18 and 65 via questionnaire employing conjoint analysis (CA). Through the utilization of this methodology, the factors influencing women's choices concerning oocyte cryopreservation were quantified.</p><p><strong>Findings: </strong>The study identified crucial factors that impact the determination to cryopreserve oocytes, such as personal financial resources, the likelihood of achieving a successful pregnancy using frozen oocytes, and the potential for infertility. The analysis reveals that a considerable number of participants perceive cryopreservation as a feasible alternative for augmenting their prospects for future procreation.</p><p><strong>Research implications: </strong>The results validate the patterns and the ways in which personal and socioeconomic elements impact choices regarding fertility. This has the potential to inform forthcoming health policies and educational initiatives that aim to provide more comprehensive support for women's fertility decisions.</p><p><strong>Social implications: </strong>The research highlights the necessity of policy and societal support for women who are contemplating oocyte cryopreservation. It is recommended that public health policies incorporate provisions for state financing of cryopreservation in order to safeguard reproductive autonomy and alleviate the fertility risk linked to the aging process.</p><p><strong>Originality/value: </strong>His research is unique in that it employs the Theory of Planned Behavior and an economic stated-preference framework to analyze the dynamics of oocyte cryopreservation decisions. This work enhances the existing body of literature by drawing attention to the socio-economic persona factors that influence choices regarding fertility preservation.</p>","PeriodicalId":12447,"journal":{"name":"Frontiers in Endocrinology","volume":"15 ","pages":"1467213"},"PeriodicalIF":3.9,"publicationDate":"2024-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11695191/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142931154","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Frontiers in Endocrinology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1